(19)
(11) EP 3 216 448 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
05.06.2019 Bulletin 2019/23

(45) Mention of the grant of the patent:
27.03.2019 Bulletin 2019/13

(21) Application number: 17152504.1

(22) Date of filing: 31.01.2013
(51) International Patent Classification (IPC): 
A61K 31/422(2006.01)
A61K 9/68(2006.01)
 A61K 9/56(2006.01)
A61P 33/00(2006.01)

(54)

PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF

PARASITIZIDE ORALE TIERMEDIZINISCHE ZUSAMMENSETZUNGEN MIT SYSTEMISCH WIRKENDEN WIRKSTOFFEN, VERFAHREN UND VERWENDUNGEN DAVON

COMPOSITIONS VÉTÉRINAIRES ORALES PARASITICIDES COMPRENANT DES AGENTS ACTIFS À ACTION SYSTÉMIQUE, PROCÉDÉS ET LEURS UTILISATIONS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 06.02.2012 US 201261595463 P

(43) Date of publication of application:
13.09.2017 Bulletin 2017/37

(62) Application number of the earlier application in accordance with Art. 76 EPC:
13703705.7 / 2811998

(73) Proprietor: Boehringer Ingelheim Animal Health USA Inc.
Duluth, GA 30096 (US)

(72) Inventors:
  • SOLL, Mark, D.
    Alpharetta, GA Georgia 30005 (US)
  • LARSEN, Diane
    Buford, GA Georgia 30519 (US)
  • CADY, Susan, Mancini
    Yardley, PA Pennsylvania 19067 (US)
  • CHEIFETZ, Peter
    East Windsor, NJ New Jersey 08520 (US)
  • GALESKA, Izabela
    Newtown, PA Pennsylvania 18940 (US)
  • GONG, Saijun
    Bridgewater, NJ New Jersey 08807 (US)

(74) Representative: D Young & Co LLP 
120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)


(56) References cited: : 
WO-A1-2011/149749
WO-A2-2009/002809
 WO-A2-2008/154528
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).